We are a research technology company based in one of Europe's most prestigious university cities, surrounded by world-class scientific institutions and an unmatched pipeline of research talent.
Edinburgh is not merely our headquarters. It is our research ecosystem. The city is home to four universities, including the University of Edinburgh (ranked 15th globally) and Heriot-Watt University (world-renowned for chemical engineering and materials science). This concentration of academic excellence creates an environment where fundamental research and commercial application intersect naturally.
The University of Edinburgh's School of Biological Sciences is a global leader in microbial ecology, synthetic biology, and evolutionary genomics. Its School of Chemistry operates the EaStCHEM research partnership — one of the largest chemistry research schools in the UK. Edinburgh Napier University contributes strength in applied biotechnology and environmental science.
Beyond the universities, Edinburgh hosts the Roslin Institute (famous for Dolly the sheep, now a CRISPR research center), the UK BioIndustry Association headquarters, and Scotland's Innovation Centre for Industrial Biotechnology (IBioIC). The city produces more scientific publications per capita than any other UK city outside London.
Top 20 globally. Leading research in synthetic biology, genomics, and evolutionary biology.
World leader in chemical engineering, materials science, and nanotechnology research.
Pioneering genetic and genomic research. CRISPR applications in agriculture and medicine.
Scotland's Industrial Biotechnology Innovation Centre. Bridging academia and industry.
Scotland produces over 10,000 STEM graduates annually, with Edinburgh universities contributing the largest share of biological sciences and chemistry graduates. The Edinburgh BioQuarter — a 350-acre life sciences campus adjacent to the Royal Infirmary of Edinburgh — houses over 3,000 researchers and is projected to create 10,000 jobs in the life sciences sector.
This talent pipeline is not theoretical. It is the reason we can build a platform that queries 6 million research papers and delivers academic-grade analysis. Our team includes researchers who have published in Nature, Science, and Cell. We understand the science because we have done the science.
Behind the Discovery Lab interface lies a network of laboratory-grade testing environments. We do not simply search databases and return results. We validate findings through:
AISCKOP Technologies operates at the intersection of microbial biology and nanotechnology research. We do not sell products. We sell research optimization.
When a company approaches us with a research challenge — whether it is finding a microbe that produces a specific enzyme, identifying a nanoparticle synthesis pathway, or validating a bioremediation concept — we deploy our platform and expertise to deliver a comprehensive research brief in a fraction of the time and cost of traditional R&D.
Our clients include pharmaceutical companies seeking novel drug delivery systems, materials companies exploring bio-based alternatives, environmental engineering firms developing bioremediation solutions, and agricultural companies optimizing biological inputs.